Posted on 13 February 202513 February 2025 Pfizer’s blockbuster ADC Adcetris nabs FDA approval to treat large B-cell lymphoma More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green light...